Equine neuronal ceroid lipofuscinosis.

This research paper documents the first known cases of Neuronal Ceroid Lipofuscinosis (NCL), a fatal neurodegenerative disorder, in horses. In the study, three horses showed symptoms such as developmental retardation, movement issues, and vision loss. Upon analysis, researchers found NCL to be the cause, thereby expanding the knowledge and recognition of this disease in animals.

Introduction to Neuronal Ceroid Lipofuscinosis

• Neuronal Ceroid Lipofuscinosis (NCL) is an inherited disorder that primarily affects the nervous system in various species, which leads to fatal outcomes in humans.
• In this study, the disease was for the first time documented in horses, marking a significant discovery in veterinary medicine.

Study of NCL in Horses

• The researchers studied three horses that displayed unusual symptoms, such as slowed movements, developmental retardation, and loss of appetite from around six months of age.
• By the time they were one year old, these horses began experiencing neurological symptoms and in one case, vision loss.
• Unfortunately, due to the progressive deterioration of their health, these horses had to be euthanized about 1.5 years after these behavioral changes were first observed.

Discovery from Necropsies and Histopathology Analysis

• Upon conducting necropsies on the euthanized horses, researchers noted abnormalities in the brain, such as slight flattening of the gyri (ridges of the brain) and discoloration.
• Microscopic examination of tissue samples (histopathology) revealed accumulated autofluorescent material in neurons throughout the brain and spinal cord. This material was also found in other parts of the horses’ bodies, including the retina, submucous and myenteric ganglia, and glial cells.
• This buildup of substances in the cells is consistent with lysosomal storage disease, a group of about 50 rare inherited metabolic disorders, to which NCL belongs.

Further Verification Through Immunohistochemistry and Electron Microscopy

• To further confirm the diagnosis of NCL, researchers performed immunohistochemistry analysis, a process that uses antibodies to detect specific proteins in the cells. The cells showed positive signals when tested with antiserum against subunit c of mitochondrial ATP synthase, a characteristic trait of NCL.
• Additionally, electron microscopy allowed the researchers to visualize fingerprint-like and rectilinear structures within the enlarged lysosomes, providing further evidence for the presence of NCL.
• Lysosomal storage disease was thus confirmed in these horses, marking the first time such a condition has been identified in this species.